InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
10
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-45.2%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Greenspan Ira Scott, Président du Conseil. Officer active across 1 company, notably Scopus BioPharma Inc.. Aggregated, 10 filings have been recorded. Breakdown: 10 buys · 0 sell. Total volume traded: €34k. Activity tracked since 23 July 2021. The latest transaction was disclosed on 27 August 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations10 total
110 shares@ US$4.921.82% mcap1.3% of flowCommon Stock, par value $0.001SEC:0001104659-21-110764
Ideal exit: 24 May 2022 (T+270)
110 shares@ US$4.921.82% mcap1.3% of flowCommon Stock, par value $0.001SEC:0001104659-21-110764:0
Ideal exit: 24 May 2022 (T+270)
500 shares@ US$4.417.44% mcap5.4% of flowCommon Stock, par value $0.001SEC:0001104659-21-109182:0
Ideal exit: 20 May 2022 (T+270)
500 shares@ US$4.415.4% of flowCommon Stock, par value $0.001SEC:0001104659-21-109182
Ideal exit: 20 May 2022 (T+270)
2,000 shares@ US$4.0427.41% mcap20.1% of flowCommon Stock, par value $0.001SEC:0001104659-21-108376:0
Ideal exit: 16 May 2022 (T+270)
2,000 shares@ US$4.0420.1% of flowCommon Stock, par value $0.001SEC:0001104659-21-108376
Ideal exit: 16 May 2022 (T+270)
1,000 shares@ US$4.1313.97% mcap10.2% of flowCommon Stock, par value $0.001SEC:0001104659-21-107826:0
Ideal exit: 14 May 2022 (T+270)
1,000 shares@ US$4.1310.2% of flowCommon Stock, par value $0.001SEC:0001104659-21-107826
Ideal exit: 14 May 2022 (T+270)
1,100 shares@ US$4.7717.65% mcap12.9% of flowCommon Stock, par value $0.001SEC:0001104659-21-096344:0
Ideal exit: 19 Apr 2022 (T+270)
1,100 shares@ US$4.7712.9% of flowCommon Stock, par value $0.001SEC:0001104659-21-096344
Ideal exit: 19 Apr 2022 (T+270)
10 of 10 declarations
About Greenspan Ira Scott
Ira Scott Greenspan is the Chairman of the Board of Scopus BioPharma Inc. He oversees the board's activities and ensures good governance of the company. His experience in the biopharmaceutical sector is valuable in guiding Scopus's strategy.
